The Pharma Data

DECEMBER 2, 2020

Kazumi was also a co-founder and CEO of Mitobridge, a start-up company developing mitochondrial drugs for the treatment of muscle and kidney diseases, until its acquisition by Astellas Pharma in 2018. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. 3, 2020 08:00 UTC.

Pharmaceuticals 52

Pharmaceuticals Synthetic Chemistry RNA Disease 52

The Pharma Data

JANUARY 27, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

FDA 52

FDA Synthetic Chemistry Assay Development Treatment 52

The Pharma Data

MAY 14, 2021

The Journal of Synthetic Chemistry confirms that broccoli leaf extracts have extremely powerful and valuable nutrients, ones that are required to maintain the good health of the prostate. Frank Neal is a pen name used for marketing purposes and to protect the author’s identity.

Packaging 52

Packaging Synthetic Chemistry Production Nurses 52

The Pharma Data

DECEMBER 4, 2021

. “Pfizer’s goal with AWS is to expedite the processes for drug discovery and development in ways that can ultimately enhance patient experiences and deliver new therapies to market. Pfizer has an extensive collection of documents that contain valuable data from a variety of drug development processes.

Drug Development 52

Drug Development Small Molecule Synthetic Chemistry Drugs 52